Literature DB >> 18008129

Anesthetic management of electroconvulsive therapy in a patient with a known history of neuroleptic malignant syndrome.

Naoko Kato, Yusuke Asakura, Misako Mizutani, Nobuhisa Kandatsu, Yoshihiro Fujiwara, Toru Komatsu.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18008129     DOI： 10.1007/s00540-007-0546-6

Source DB:  PubMed          Journal:  J Anesth        ISSN： 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  9 in total

Review 1.  Neuroleptic malignant syndrome.

Authors:  P Adnet; P Lestavel; R Krivosic-Horber
Journal:  Br J Anaesth       Date:  2000-07       Impact factor: 9.166

Review 2.  Anesthesia for electroconvulsive therapy.

Authors:  Zhengnian Ding; Paul F White
Journal:  Anesth Analg       Date:  2002-05       Impact factor: 5.108

3.  The WHO analgesic ladder and neuroleptic malignant syndrome.

Authors:  Y Asakura; Y Fujiwara; T Komatsu
Journal:  Acta Anaesthesiol Scand       Date:  2006-11       Impact factor: 2.105

4.  Repeated anesthesia for a patient with neuroleptic malignant syndrome.

Authors:  J Geiduschek; S A Cohen; A Khan; B F Cullen
Journal:  Anesthesiology       Date:  1988-01       Impact factor: 7.892

Review 5.  Electroconvulsive therapy.

Authors:  A Khan; M H Mirolo; D Hughes; L Bierut
Journal:  Psychiatr Clin North Am       Date:  1993-09

6.  Low dose mivacurium is less effective than succinylcholine in electroconvulsive therapy.

Authors:  E W Cheam; L A Critchley; P T Chui; J C Yap; V W Ha
Journal:  Can J Anaesth       Date:  1999-01       Impact factor: 5.063

Review 7.  Malignant hyperthermia and ECT.

Authors:  O F Yacoub; D H Morrow
Journal:  Am J Psychiatry       Date:  1986-08       Impact factor: 18.112

8.  Malignant hyperthermia susceptibility in neuroleptic malignant syndrome.

Authors:  S N Caroff; H Rosenberg; J E Fletcher; T D Heiman-Patterson; S C Mann
Journal:  Anesthesiology       Date:  1987-07       Impact factor: 7.892

9.  Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia.

Authors:  J Fujii; K Otsu; F Zorzato; S de Leon; V K Khanna; J E Weiler; P J O'Brien; D H MacLennan
Journal:  Science       Date:  1991-07-26       Impact factor: 47.728
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.